United States · FDA National Drug Code directory
RiaSTAP
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63833-891_703efe5b-eb9f-4690-abb8-e446feaa702f
- Product NDC
- 63833-891
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- FIBRINOGEN HUMAN
- Labeler
- CSL Behring GmbH
- Marketing category
- BLA
- Marketing start / end (source format)
- 20090116
- Source listing expiry
- 20271231
Source-listed ingredients
- FIBRINOGEN HUMAN — 1300 mg/50mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (63833-891-51) / 50 mL in 1 VIAL, SINGLE-USE (63833-891-90) · 63833-891-51
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →